CMS Ready To Reassess Coverage Of Old Technologies, Eyeing New Ones
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Medicare & Medicaid Services is increasing the amount of interaction between the agency's coverage and payment sides as new technologies enter the U.S. market, including drug-eluting stents